The Synaps Network gathers experts from a very wide range of disciplines. It promotes a genuine multidisciplinary and novel approach to gliobastoma treatment.
The Synaps’ scientific scope includes the fields of neurosurgery but also medical engineering, optical and medical physics, medical imaging and immunology :
  • computer scientists, physicists and mathematicians for developing treatment planning system, formalizing metrological constraints
  • surgeons for therapeutic management and expertise of the pathology
  • radiologists and nuclear physicians for planning imaging, control and monitoring
  • immunologists to study the immune response
  • social sciences experts that play a decisive role in supporting patients and families, assessing the quality of life and acceptance of therapy.
How to join Synaps

Synaps is looking for partners to enrich its team and speed up research. Do not hesitate to contact us to screen possible scientific or medical collaborations.
Picture
Copyright ONCO-THAI - CHRU Lille

Partners

ONCO-THAI Inserm U1189 is a research team specialized in therapies using LASER light located in Lille, France.
Inserm (French Institute of Health and Medical Research) is a French biomedical and public health research institution.
​Lille University Hospital is the largest university hospital campus in Europe and a reference neurosurgery platform.
University of Lille is one of the largest university in Europe and brings together world famous researchers in laboratories equipped with the latest technology.
ECRIN is a public, non-profit organisation that facilitates the development and implementation of multinational clinical trials in Europe
Leitat Technological Center is a technological institute with the mission of collaborating with companies and other entities to create economic, social and sustainable value by RD projects and technology processes from innovation and creativity.
Intermedic is a company with extensive experience in the development of high technology LASER platforms.
IDDI offers a wide range of flexible services in biostatistical design and analysis, medical writing, data management, clinical operations, centralised databases for phase I-IV clinical trials.
The Medical University of Graz is a sustainable and quality-oriented health university. As an innovator and excellent partner in research, teaching and continuing education at levels of excellence, the University has earned national and international recognition.
OP2 Drugs is an SME specialized in the development and marketing of innovative drugs based on already registered molecules.
Oncoradiomics is a spin-off company which will achieve more effective, individualized screening & therapy for cancer patients thanks to quantitative imaging.
The Erasme hospital maintains a national and international reputation for clinical practice, research and education.